,Magnera has introduced a next-generation nonwoven textile solution that delivers high-performance fluid repellency without the use of PFAS, addressing a critical need in healthcare and other protective applications. While PFAS have long been valued for durability and resistance, growing evidence of their environmental persistence and potential health risks has driven demand for safer alternatives. Magneras proprietary innovation meets stringent industry requirements for protection, comfort, and compliance, offering healthcare professionals reliable performance without adding harmful substances. This innovation arrives as global regulations tighten, with the European Union proposing phased PFAS restrictions under REACH and several U.S. states already enforcing bans across consumer and textile products. As manufacturers face supply constraints and rising costs from PFAS phase-outs, Magnera provides a timely, future-ready solution. Its nonwoven fabrics combine effective fluid resistance, breathability, and wearer comfort, while aligning with evolving regulations and advancing environmental responsibility across industries.
Consult
